Replies to post #724386 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Horse,

That's not my intention to let you read the website.

IMO, the DC technology that the company adopted is deeply connected to the one developed by NWBO.

Linkinvax doesn't develop its own patent. But it depends on the patent pool licensed from 17 institutions. Can you see if there is another institution other than RevImmune that has DC technology? The answer is no.

[skitahoe]

I know many say that DCVax has the potential to go against viruses and possibly other diseases, but I'd like to understand how. In DCVax-L the tumor plus leukapheresis is used to make the vaccine. In Direct, you don't have the tumor, but Direct is injected into it to essentially make it on site.

I understand that essentially DCVax-Direct can be made for anyone, but where should it be injected to achieve the desired result.

I'm not saying it won't work, just trying to understand how it would work.

If DCVax-Direct, or some variation of it that's covered under NWBO patents truly works for other diseases, even my wildest predictions of where NWBO could go with success in solid cancers would be way too low.

Gary